July 17, 2017
Biophytis to Host Key Opinion Leader Breakfast on Sarcopenia in New York – July 28, 8:00 am
Biophytis to Host Key Opinion Leader Breakfast on Sarcopenia in New York – July 28, 8:00 am
Biophytis announces the issuance of a €3 million tranche of ORNANEBSA. Read the Press Release
Video interview of Stanislas Veillet, CEO of Biophytis : “The schedule announced last year is followed”. Click here to watch the vidéo.
Participation of Biophytis to the European MIDCAP event in Hotel Pullman Paris Eiffel Tour – June 28 & 29, 2017
Results of the General Shareholders’ Meeting held on June 16, 2017. Read the Press release
BIOPHYTIS selects SGS Life Science Services to conduct MACA-PK, clinical study of Macuneos in dry AMD. Read the Press Release
Participation of Biophytis to Bio€quity Europe 2017. May 22-23, 2017. Marriott Rive Gauche, Paris, France
Biophytis announces the issuance of a €3 million tranche of ORNANEBSA. Read the Press Release
First patient-in in the United States and opening of 2 clinical centers for the SARA-OBS study on Sarcopenia. Read the Press Release
The SARA clinical program – Towards a first treatment for Sarcopenia. Interviews conducted during ICSFR 2017. Watch the video